PRESS RELEASE "Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation"│TOPICS│ImmuniT Research Inc.

ImmuniT Research Inc.

8th floor Shin Kokusai Building,
3-4-1 Marunouchi, Chiyoda-ku,
Tokyo 100-0005 Japan
Tel : +81-3-6689-3645

PRESS RELEASE September 25th, 2017

PRESS RELEASE "Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation"